| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010
|
Ouandaogo, Claude-Roger
|
|
2012
|
30 |
S2 |
p. B46-B51
nvt p.
|
artikel
|
| 2 |
Can we defeat meningococcal disease in low and middle income countries?
|
Greenwood, Brian
|
|
2012
|
30 |
S2 |
p. B63-B66
nvt p.
|
artikel
|
| 3 |
Can we, should we, eradicate the meningococcus?
|
Maiden, Martin C.J.
|
|
2012
|
30 |
S2 |
p. B52-B56
nvt p.
|
artikel
|
| 4 |
Considerations for controlling invasive meningococcal disease in high income countries
|
Holst, Johan
|
|
2012
|
30 |
S2 |
p. B57-B62
nvt p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2012
|
30 |
S2 |
p. CO2-
1 p.
|
artikel
|
| 6 |
Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
|
Djingarey, Mamoudou H.
|
|
2012
|
30 |
S2 |
p. B40-B45
nvt p.
|
artikel
|
| 7 |
Future challenges in the elimination of bacterial meningitis
|
Bottomley, Matthew J.
|
|
2012
|
30 |
S2 |
p. B78-B86
nvt p.
|
artikel
|
| 8 |
History of meningococcal vaccines and their serological correlates of protection
|
Vipond, Caroline
|
|
2012
|
30 |
S2 |
p. B10-B17
nvt p.
|
artikel
|
| 9 |
Meningococcal disease: Clinical presentation and sequelae
|
Pace, David
|
|
2012
|
30 |
S2 |
p. B3-B9
nvt p.
|
artikel
|
| 10 |
Meningococcal disease from the public health policy perspective
|
Black, Steven B.
|
|
2012
|
30 |
S2 |
p. B37-B39
nvt p.
|
artikel
|
| 11 |
Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease
|
Dull, Peter M.
|
|
2012
|
30 |
S2 |
p. B18-B25
nvt p.
|
artikel
|
| 12 |
Preface
|
Rappuoli, Rino
|
|
2012
|
30 |
S2 |
p. B1-B2
nvt p.
|
artikel
|
| 13 |
The challenge of post-implementation surveillance for novel meningococcal vaccines
|
Snape, Matthew D.
|
|
2012
|
30 |
S2 |
p. B67-B72
nvt p.
|
artikel
|
| 14 |
The changing and dynamic epidemiology of meningococcal disease
|
Halperin, Scott A.
|
|
2012
|
30 |
S2 |
p. B26-B36
nvt p.
|
artikel
|
| 15 |
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
|
Serruto, Davide
|
|
2012
|
30 |
S2 |
p. B87-B97
nvt p.
|
artikel
|
| 16 |
The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines
|
Vogel, Ulrich
|
|
2012
|
30 |
S2 |
p. B73-B77
nvt p.
|
artikel
|
| 17 |
Towards a meningitis free world—Can we eliminate meningococcal meningitis?
|
Davie, Sue
|
|
2012
|
30 |
S2 |
p. B98-B105
nvt p.
|
artikel
|
Tijdschrift beschrijving